China Business Blog - Aggregated China Business Blogs
Aggregated China Business Blogs
Sequoia China Leads $150 Million Round In Drug Developer Visen Pharma
Aggregated Source: China Money Network

Chinese new endocrine drug developer Visen Pharma announced the completion of US$150 million in Series B financing, led by Sequoia China Fund. Aobo Capital, Sherpa Investment, Cormorant, HBM Healthcare Investments, Dingfeng Biotech Capital, Logos Capital, Chenling Capital also participated in the investment. Existing shareholders Ascendis Pharma A/S, Vivo Capital, Sofinnova Investments continued to invest in […]

Sequoia China Leads $150 Million Round In Drug Developer Visen Pharma comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.

Original URL: Click here to visit original article
Copyright China Money Network





Warning: Use of undefined constant php - assumed 'php' (this will throw an Error in a future version of PHP) in /home/chinabus/public_html/wp-content/themes/aggregation-colors/single.php on line 80